Cathay Biotech Inc. (SHA:688065)
China · Delayed Price · Currency is CNY 49.46
+0.22 (0.45%)
Jul 6, 2026, 3:00 PM CST
Cathay Biotech Market Cap
Cathay Biotech has a market cap or net worth of 35.49 billion as of July 6, 2026. Its market cap has increased by 3.58% in one year.
Market Cap
35.49B
Enterprise Value
30.79B
Revenue
3.39B
Ranking
n/a
PE Ratio
59.73
Stock Price
49.46
Market Cap Chart
Since August 12, 2020, Cathay Biotech's market cap has decreased from 65.42B to 35.49B, a decrease of -45.76%. That is a compound annual growth rate of -9.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 35.49B | -1.12% |
| Dec 31, 2025 | 35.89B | 59.12% |
| Dec 31, 2024 | 22.56B | -29.54% |
| Dec 29, 2023 | 32.01B | -10.45% |
| Dec 30, 2022 | 35.75B | -53.44% |
| Dec 31, 2021 | 76.79B | 116.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hubei Xingfa Chemicals Group | 47.71B |
| Jinan Shengquan Group Share Holding | 47.09B |
| Zhejiang Sanmei Chemical Industry | 45.59B |
| Inner Mongolia Junzheng Energy & Chemical Group | 39.74B |
| FSPG Hi-Tech CO. | 33.83B |
| Hubei Zhenhua Chemical | 33.29B |
| Xinfengming Group | 32.74B |
| Levima Advanced Materials | 30.89B |